ROX improves iron utilization parameters by decreasing ferritin, TSAT, and hepcidin and increasing TIBC and transferrin, thus enhancing the utilization of iron in the body; this may lead to iron deficiency. The gene discussed is TF; the disease is Iron deficiency anemia.